Replication of primate foamy viruses in natural and experimental hosts

Current Topics in Microbiology and Immunology

Volumn 277, Issue , 2003, Pages 161-180

  Falcone, V ^a   Schweizer, M ^b   Neumann Haefelin, D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; GENETIC VARIABILITY; HOST; IMMUNE RESPONSE; MAMMAL; MOUTH MUCOSA; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SALIVA; SPUMA VIRUS; VIRUS CARRIER; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALIA; HUMAN SPUMARETROVIRUS; MAMMALIA; PRIMATES; SPUMAVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0037910268     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-55701-9_7     Document Type: Review

References (78)

1. Achong BG, Mansell PWA, Epstein MA, Clifford P (1971) An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 46:299-302
2. Aguzzi A (1993) The foamy virus family: molecular biology, epidemiology and neuropathology. Biochim Biophys Acta 1155:124
3. Aguzzi A, Marino S, Tschopp R, Rethwilm A (1996) Regulation of expression and pathogenic potential of human foamy virus in vitro and in transgenic mice. Curr Top Microbiol Immunol 206:243-273
4. Bieniasz PD, Rethwilm A, Pitman R, Daniel MD, Chrystie I, McClure MO (1995a) A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology 207:217-228
5. Bieniasz PD, Weiss RA, McClure MO (1995b) Cell cycle dependence of foamy retrovirus infection. J Virol 69:7295-7299
6. Blewett EL, Black DH, Lerche NW, White G, Eberle R (2000) SFV infection in a baboon breeding colony. Virology 278:183-193
7. Bock M, Heinkelein M, Lindemann D, Rethwilm A (1998) Cells expressing the human foamyvirus (HFV) accessory bet protein are resistant to productive HFV superinfection. Virology 250:194-204
8. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I (1991) Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 253:555-557
9. Broussard SR, Comuzzie AG, Leighton KL, Leland MM, Whitehead EM, Allan JS (1997) Characterization of new simian foamy viruses from African nonhuman primates. Virology 237:349-59
10. Brown P, Morreau-Dubois C, Gajdusek DC (1982) Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retroviral latency. Arch Virol 71:229-234
11. Callahan ME, Switzer WM, Matthews AL, Roberts BD, Heneine W, Folks TM, Sandstrom PA (1999) Persistent zoonotic infection of a human with a simian foamy virus in the absence of an intact orf-2 accessory gene. J Virol 73:9619-24
12. Cameron, KR, Birchall SM, Moses, MA (1978) Isolation of foamy virus from patient with dialysis encephalopathy. Lancet II:796
13. Carski T (1960) A fluorescent antibody study of the simian foamy agent. J Immunol 84:426-433
14. Colas S, Bourge JF, Wybier J, Chelbi-Alix MK, Paul P, Emanoil-Ravier R (1995) Human foamy virus infection activates class I major histocompatibility complex antigen expression. J Gen Virol 76:661-667
15. Enders JF, Peebles TC (1954) Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86:277-286
16. Falcone V, Leupold J, Clotten J, Urbanyi E, Herchenroeder O, Spatz W, Volk B, Boehm N, Toniolo A, Neumann-Haefelin D, Schweizer M (1999a) Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257:7-14
17. Falcone V, Schweizer M, Toniolo A, Neumann-Haefelin D, Meyerhans A (1999b) Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects. J Virol 73:1724-1728
18. Feldman, MD, Dunnick NR, Barry DW, Paerkman PD (1975) Isolation of foamy virus from rhesus, African green and cynomolgus monkey leukocytes. J Med Primatol 4:287-295
19. Felsenstein J (1989) PHYLIP (phylogeny inference package) version 3.2. Cladistics 5:164-166
20. Fleming WA, Clarke JK (1970) Fluorescence assay of foamy virus. J Gen Virol 6:277-284
21. Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure M, Rethwilm A (1994) Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol 75:2635-2644
22. Heneine W, Switzer WM, Sandstrom P, Brown J, Shanmugam V, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks, TM (1998) Identification of a human population infected with simian foamy virus. Nat Med 4:403-407
23. Hirata RK, Miller AD, Andrews RG, Russell DW (1996) Transduction of hematopoietic cells by foamy virus vectors. Blood 88:3654-61
24. Hirsch VM, Dapolito G, Goeken R, Campbell BJ (1995) Phylogeny and natural history of the primate lentiviruses, SIV and HIV. Curr Opin Genet Dev 5:798-806
25. Hooks JJ, Burns W, Hayashi K, Geis S, Notkins AL (1976) Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infect Immun 14:1172-1178
26. Hooks JJ, Gibbs CJ, Chou R, Howk R, Lewis M, Gajdusek DC (1973) Isolation of a new simian foamy virus from a spider monkey brain culture. Infect Immun 8:804-813
27. Hooks JJ, Gibbs CJ, Cutchins EC, Rogers NG, Lampert P, Gajdusek DC (1972) Characterization and distribution of two new foamy viruses isolated from chimpanzees. Arch Ges Virusforsch 38:38-55
28. Hooks JJ, Gibbs CJ (1975) The foamy viruses. Bacteriol Rev 39:169-185
29. Hooks JJ, Detrick-Hooks B (1979) Simian foamy virus-induced immunosuppression in rabbits. J Gen Virol 44:383-390
30. Howcroft TK, Strebel K, Martin MA, Singer DS (1993) Repression of MHC-1 gene promoter activity by two-exon tat of HIV. Science 260:1320-1322
31. Imrich H, Müller JG, Lindemann D, Heinkelein M, Rethwilm A (2003) Pathogenicity of Foamy Virus in arhymic mice. (Submitted)
32. Johnston PB (1961) A second immunological type of simian foamy virus: monkey throat infection and unmasking by both types. J Infect Dis 109:1-9
33. Johnston PB (1971) Taxonomic features of seven serotypes of simian and ape foamy viruses. Infect Immun 3:793-799
34. Johnston PB (1974) Studies on simian foamy viruses and syncytium-forming viruses of lower animals. Lab Anim Sci 24:159-166
35. Kralli A, Ge R, Graeven U, Ricciardi RP, Weinmann R (1992) Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element. J Virol 66:6979-6988
36. Lecellier CH, Saïb A (2000) Foamy viruses: Between retroviruses and pararetroviruses. Virology 271:1-8
37. Linial M (2000) Why aren't foamy viruses pathogenic? Trends Microbiol 289:284-289
38. Linial ML (1999) Foamy viruses are unconventional retroviruses. J Virol 73:1747-1755
39. McClure MO, Bieniasz PD, Schulz TF, Chrystie IL, Simpson G, Aguzzi A, Hoad JG, Cunningham A, Kirkwood J, Weiss RA (1994) Isolation of a new foamy retrovirus from orangutans. J Virol 68:7124-7130
40. McClure MO, Erlwein O (1995) Foamy viruses - pathogenic or therapeutic potential. Rev Med Virol 5:229-237
41. Meiering CD, Linial ML (2001) Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 14:165-176
42. Mergia A, Chari S, Kolson DL, Goodenow MM, Ciccarone T (2001) The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and human PBLs. Virology 280:243-252
43. Mergia A, Leung NJ, Blackwell J (1996) Cell tropism of the simian foamy virus type 1 (SFV-1). J Med Primatol 25:2-7
44. Mikovits JA, Hoffman PM, Rethwilm A, Ruscetti FW (1996) In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus. J Virol 70:2774-2780
45. Neumann-Haefelin D, Fleps U, Renne R, Schweizer M (1993) Foamy viruses. Intervirology 35:196-207
46. Neumann-Haefelin D, Rethwilm A, Bauer G, Gudat F, zur Hausen H (1983) Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol 172:75-86
47. Parks WP, Todaro GJ, Scolnick EM, Aaronson SA (1971) RNA dependent DNA polymerase in primate syncytium-forming (foamy) viruses. Nature 229:258-260
48. Regad T, Saïb A, Lallemand-Breitenbach V, Pandolfi PP, de Thé H, Chelbi-Alix MK (2001) PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20:3495-3505
49. Rhodes-Feuillette A, Lasneret J, Paulien S, Ogunkolade W, Périès J, Canivet M (1990) Effects of human recombinant alpha and gamma and that of highly purified natural beta interferons on simian spumavirinae prototype (simian foamy virus 1) multiplication in human cells. Res Virol 141:31-43
50. Rhodes-Feuillette A, Saal F, Lasnaret J, Dubouch P, Périès J (1979) Isolation and characterization of a new simian foamy virus serotype from lymphocytes of a Papio cynocephalus baboon. J Med Primatol 8:308-320
51. Rhodes-Feuillette A, Saal F, Lasneret J, Santillana-Hayat M, Périès J (1987) Studies on in vitro interferon induction capacity and interferon sensitivity of simian foamy viruses. Arch Virol 97:77-84
52. Rogers N, Basnight M, Gibbs GJ, Gajdusek DC (1967) Latent viruses in chimpanzees with experimental kuru. Nature 216:446-449
53. Rösener M, Hahn H, Kranz M, Heeney J, Rethwilm A (1996) Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol 48:222-226
54. Rustigian R, Johnston P, Reihart, H (1955) Infection of monkey kidney tissue cultures with virus-like agents. Proc Soc Exp Biol Med 88:8-16
55. Sabile A, Rhodes-Feuillette A, Jaoui FZ, Tobaly-Tapiero J, Giron ML, Lasneret J, Périès J, Canivet M (1996) In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus. Res Virol 147:29-37
56. Saïb A, Koken HM, van der Spek P, Périès J, de Thé H (1995b) Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J Virol 69:5261-5268
57. Saïb A, Neves M, Giron ML, Guillemin MC, Valla J, Périès J, Canivet M (1997) Longterm persistent infection of domestic rabbits by the human foamy virus. Virology 228:263-268
58. Saïb A, Périès J, de Thé H (1995a) Recent insights into the biology of the human foamy virus. Trends Microbiol:173-178
59. Saïb A, Périès J, de Thé H (1993) A defective human foamy provirus generated by pregenome splicing. EMBO J 12:4439-4444
60. Santillana-Hayat M, Rozain F, Bittoun P, Chopin-Robert C, Lasneret J, Périès J. Canivet M (1993) Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res Virol 144:389-396
61. Sawada M, Suzumura A, Yoshida M, Marunouchi T (1990) Human T-cell leukemia virus type 1 transactivator induces class I major histocompatibility complex antigen expression in glial cells. J Virol 64:4002-4006
62. Schmidt M, Niewiesk S, Heeney J, Aguzzi A, Rethwilm A (1997) Mouse model to study the replication of primate foamy viruses. J Gen Virol 78:1929-1933
63. Schweizer M, Corsten B, Neumann-Haefelin D (1988) Heterogeneity of primate foamy virus genomes. Arch Virol 99:125-134
64. Schweizer M, Falcone V, Gaenge J, Turek R, Neumann-Haefelin D (1997) Simian foamy virus isolated from an accidentally infected human individual. J Virol 71:4821-4824
65. Schweizer M, Fleps U, Jaeckle A, Renne R, Turek R, Neumann-Haefelin D (1993) Simian foamy virus type 3 (SFV-3) in latently infected Vero cells: Reactivation by demethylation of proviral DNA. Virology 192:663-666
66. Schweizer M, Neumann-Haefelin D (1995) Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 207:577-582
67. Schweizer M, Schleer H, Pietrek M, Liegibel J, Falcone V, Neumann-Haefelin D (1999). Genetic stability of foamy viruses: long-term study in an African green monkey population. J Virol 73:9256-9265
68. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995) Markers of foamy virus (FV) infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected FV prevalence in man. AIDS Res Hum Retrovir 11:161-170
69. Scolnick E, Rands E, Aaronson SA, Todaro GJ (1970) RNA-dependent DNA polymerase activity in five RNA viruses: Divalent cation requirements. Proc Natl Acad SCI USA 67:1789-1796
70. Stiles GE, Bittle JL, Cabasso UJ (1964) Comparison of simian foamy virus strains including a new serological type. Nature 201:1350-1351
71. Swack NS, Hsiung GD (1975) Pathogenesis of simian foamy virus infection in natural and experimental hosts. Infect Immun 12:470-474
72. von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M (1996) Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 221:240-244
73. Voss G, Nick S, Stahl-Hennig C, Ritter K, Hunsmann G (1992) Generation of macaque B-lymphoblastoid cell lines with simian Epstein-Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. J Virol Methods 39:185-195
74. Weiss RA (1988) Foamy retroviruses. A virus in search of a disease. Nature 333:497-498
75. Weiss RA (1996) Foamy viruses bubble on. Nature 380:201
76. Westarp ME, Fuchs D, Bartmann P, Hoff-Jorgensen R, Clausen J, Wachter H, Kornhuber HH (1993) Amyotrophic lateral sclerosis: an enigmatic disease with B-cellular and anti-retroviral immune responses. Eur J Med 2:327-332
77. Wybier-Franqui J, Tobaly-Tapiero J, Coronel A, Giron ML, Chopin-Robert C, Périès J, Emanoil-Ravier R (1995) Human foamy virus DNA forms and expression in persistently infected Dami megakaryocytic cells. AIDS Res Hum Retrovir 11:829-36
78. Yu SF, Stone J, Linial ML (1996) Productive persistent infection of hematopoietic cells by human foamy virus. J Virol 70:1250-1254